[HTML][HTML] Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in Alzheimer's disease
… We also discuss the key role of N-methyl-d-aspartate receptor (… In the brains of patients
with Alzheimer-type dementia, the … d-cycloserine can facilitate NMDAR–ionophore complex …
with Alzheimer-type dementia, the … d-cycloserine can facilitate NMDAR–ionophore complex …
Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
P Chakraborty, A Dey, AV Gopalakrishnan… - Ageing Research …, 2023 - Elsevier
… formulate a complex glutamatergic network in the brain that … The iGluRs include N-methyl-D-aspartate
(NMDA), α-amino-3… the NMDA ion channel pore and facilitate the passage of Ca 2 …
(NMDA), α-amino-3… the NMDA ion channel pore and facilitate the passage of Ca 2 …
Antimicrobial therapy and the potential mechanisms in Alzheimer's disease
X Song, J Chen, Z Hou, N Xie - Neuroscience Letters, 2021 - Elsevier
… cerebral brain flow (CBF). Secondly, rapamycin promotes the degradation of Aβ and Tau by
activating … shed light on that d-cycloserine improved difficult discriminations in the pattern …
activating … shed light on that d-cycloserine improved difficult discriminations in the pattern …
[HTML][HTML] Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic
G Olivero, A Roggeri, A Pittaluga - International Journal of Molecular …, 2023 - mdpi.com
… of patients suffering from brain disorders characterized by … neurodegenerative disorders
including Alzheimer’s disease (… C1q binds the antibody–antigen complexes and activates an …
including Alzheimer’s disease (… C1q binds the antibody–antigen complexes and activates an …